Document Detail

Soluble Endothelial Protein C Receptor and Coagulation Parameters as Prognostic Factors in Non-Small Cell Lung Cancer.
MedLine Citation:
PMID:  23323811     Owner:  NLM     Status:  Publisher    
Association between cancer and thrombosis is well-known and occurrence of thrombotic complications in patients with malignancies commonly correlates with poor prognosis[1]. The protein C pathway is the main natural in-vivo anticoagulant mechanism and abnormalities such as acquired activated protein C (APC) resistance or congenital APC resistance, mostly due to factor V Leiden G1691A mutation, are major risk factors of venous thromboembolism (VTE) with odds ratio (OR) of 2.5 and 2.0-7.0, respectively[2-4]. © 2013 International Society on Thrombosis and Haemostasis.
Galit Sarig; Anat Meir; Mira Wollner; Benjamin Brenner; Nissim Haim
Publication Detail:
Type:  LETTER     Date:  2013-1-17
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  -     ISSN:  1538-7836     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 International Society on Thrombosis and Haemostasis.
Hematology Laboratory, Technion-Israel Institute of Technology; Thrombosis and Hemostasis Unit, Department of Hematology and Bone Marrow Transplantation, Technion-Israel Institute of Technology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Discourse analytic research on mental distress: A critical overview.
Next Document:  Low blood lead concentrations and thyroid function of American adults.